Health Ministry Questions Reliability of Vasculitis Drug Approval Data
The Health Ministry has raised concerns about the reliability of data used to approve a drug for vasculitis treatment. The ministry is scrutinizing the approval process and the evidence supporting the drug's efficacy and safety. This questioning aims to ensure that the drug meets stringent standards before it is widely prescribed.
The Japan Times·




